Neogen Corporation operates in food safety diagnostics with significant international revenue exposure, but declining top-line growth, weak quality scores, and a high concentration in a single product segment create structural headwinds that outweigh its favorable momentum setup.
Thesis pillars
- Revenue Decline Quality Floor↑Improving
- Food Safety Segment Concentration↑Improving
- Earnings Consistency Mixed→Stable
- +1 more pillar — see the Why tab for full reasoning
Neogen Corporation (NEOG) Stock Analysis
Healthcare · Medical Devices
Sell if holding. Engine safety override at $12.00: Quality below floor (3.6 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10. Specifically: Below-average business quality.
Neogen develops and sells food safety and animal safety products, including diagnostic test kits, culture media, genomics services and animal health products, to customers worldwide. Food Safety was about 71% of fiscal 2025 revenue and sales outside the U.S. were about 50%. No... Read more
Sell if holding. Engine safety override at $12.00: Quality below floor (3.6 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10. Specifically: Below-average business quality. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.7/10, moderate confidence.
Passes 5/8 gates (clean insider activity, news events none recent, earnings proximity 86d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
About Neogen Corporation
About Neogen Corporation
Neogen's Food Safety segment -- diagnostic test kits and culture media sold to food and feed producers -- generated 71.3% of total revenue in fiscal 2025, up from 66.5% two years earlier following the 2022 Reverse Morris Trust combination with 3M's Food Safety Division, while the Animal Safety segment contributed the remaining 28.7%. Sales to customers outside the United States accounted for 50.2% of fiscal 2025 revenue, and the company manufactures products across facilities in the U.S., U.K., Ireland and Brazil.
Neogen earns Food Safety revenue mainly from single-use diagnostic test kits and culture media that detect pathogens, allergens, toxins and sanitation issues, sold to food and feed processors and regulatory agencies, with royalty payments of 2% to 10% of revenue owed on products using licensed detection technology. The Animal Safety segment sells veterinary instruments, pharmaceuticals, vaccines, parasiticides, rodent and insect control products, and genomics testing services through veterinarians, retailers, livestock producers and distributors, and in April 2025 the company agreed to sell its global Cleaners and Disinfectants business. Neogen distributes through its own sales force in 28 countries outside the U.S. plus a network of distributors reaching more than 100 countries, and it operates genomics labs in six countries. Certain Food Safety product lines depend on a sole or single-source supplier or vendor for raw materials, a dependency the company flags directly in its risk factors.
Show full overview
Neogen's sole-source supplier risk is compounded by proprietary sourcing: the 10-K discloses that it currently purchases some raw materials and products from sole or single sources, and that some of these inputs are proprietary and therefore cannot be readily or easily replaced by alternative sources. That combination -- single-source plus non-substitutable -- sits alongside a separate risk that the company's Food Safety reporting unit took goodwill impairment charges in the second and fourth quarters of fiscal 2025 tied to difficulties integrating the 3M Food Safety business, a transaction that made pre-merger Neogen Food Safety Corporation stockholders owners of roughly 50.1% of combined shares in September 2022.
See also: Healthcare · Medical Devices
From Neogen Corporation's most recent 10-K filing, extracted October 11, 2026.
Recent developments
updated 2026-10-13Recent Developments — Neogen Corporation
Latest news
- NEWS Why Is Neogen Stock Gaining Thursday? — benzinga Oct 8, 2026 positive
- NEWS Reported Earlier, Neogen Outlines Growth And Margin Expansion Strategy At 2026 Investor Day, Targeting High-Single-Digit — benzinga Oct 8, 2026 positive
- NEWS Neogen Shifts Focus to Scale Profitable Growth — benzinga Oct 7, 2026 positive
- NEWS 12 Health Care Stocks Moving In Wednesday's Pre-Market Session — benzinga Oct 7, 2026 neutral
- NEWS Why Penguin Solutions Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket — benzinga Oct 7, 2026 neutral
Generated 2026-10-13T11:37:17Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Material Events(8-K, last 90d)
- 2026-03-30Item 5.02MEDIUMNeogen announced that Amy Rocklin, Chief Legal and Administrative Officer, will leave the Company effective March 31, 2026. No reason or successor named in the filing text provided.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Unprofitable operations — net margin -6.3%. Quality floor flags this regardless of sector context.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $12.00: Quality below floor (3.6 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10. Specifically: Below-average business quality. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $11.16. Score 5.7/10, moderate confidence.
Take-profit target: $13.97 (-0.8% upside). Prior stop was $11.16. Stop-loss: $11.16.
Target reached (-0.8% upside); Quality below floor (3.6 < 4.0).
Neogen Corporation trades at a P/E of N/A (forward 28.8). TrendMatrix value score: 5.3/10. Verdict: Sell.
11 analysts cover NEOG with a consensus score of 4.0/5. Average price target: $14.
What does Neogen Corporation do?Neogen develops and sells food safety and animal safety products, including diagnostic test kits, culture media,...
Neogen develops and sells food safety and animal safety products, including diagnostic test kits, culture media, genomics services and animal health products, to customers worldwide. Food Safety was about 71% of fiscal 2025 revenue and sales outside the U.S. were about 50%. No single customer or distributor accounted for 10% or more of revenue.